Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck receives CRL from the FDA for TECOS study with sitagliptin

cphi-onlineApril 10, 2017

Tag: Merck , FDA

PharmaSources Customer Service